Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
AbbVie’s $1.4 Billion Acquisition of Aliada Therapeutics
Blackstone and Vista Equity Partners’ $8.4 Billion Acquisition of Smartsheet
Fenwick & West is representing Smartsheet on the transaction, while Kirkland & Ellis and Simpson Thacher & Bartlett are representing Blackstone and Vista Equity Partners. Smartsheet...
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
Incyte’s $750 Million Acquisition of Escient Pharmaceuticals
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
Vista Equity Partners’ $1.5 Billion Acquisition of Model N
Kirkland & Ellis is representing Vista Equity Partners in the transaction, and Fenwick & West is representing Model N. Vista Equity Partners, which announced its definitive...
iRhythm Technologies’ $661.25 Million Convertible Senior Notes Offering
Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
Coinbase Global’s $1.1 Billion Convertible Notes Offering
Fenwick & West represented Coinbase Global, Inc. in the offering. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the...
Clearlake Capital Group and Insight Partners’ $4.4 Billion Acquisition of Alteryx
Sidley Austin is advising Clearlake on the transaction, and Willkie Farr & Gallagher is advising Insight, while Wilson Sonsini Goodrich & Rosati and Fenwick & West...
Chegg’s $150 Million Accelerated Share Repurchase
Fenwick & West represented Chegg, Inc. in the deal. Chegg, Inc (NYSE: CHGG) announced its accelerated share repurchase agreement (“ASR”) with Morgan Stanley Bank, National Association,...
Standard BioTools’ Merger with SomaLogic
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
Wonder Group’s $103 Million Acquisition of Blue Apron
Fenwick & West represented Wonder Group in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Blue Apron Holdings. Wonder Group (“Wonder”) announced that it has...
Shockwave Medical’s $750 Million Convertible Senior Notes Offering
Fenwick & West represented Shockwave Medical, Inc. in the transaction. Shockwave Medical, Inc. (Nasdaq: SWAV) announced its $750 million offering of 1.00% convertible senior notes due 2028...